Erythropoietin-alfa During Neoadjuvant Chemotherapy for Locally Advanced Esophagogastric Adenocarcinoma

Annals of Thoracic Surgery

Volumn 82, Issue 1, 2006, Pages 293-297

  Abbrederis, Kathrin ^a   Bassermann, Florian ^a   Schuhmacher, Christoph ^b   Voelter, Verena ^c   Busch, Raymonde ^a   Roethling, Nadine ^a   Sendler, Andreas ^b   Siewert, Joerg R ^b   Peschel, Christian ^a   Lordick, Florian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ERYTHROPOIETIN; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; OXALIPLATIN; PACLITAXEL; PLATINUM DERIVATIVE; RECOMBINANT ERYTHROPOIETIN;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE TRANSFUSION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; ANASTOMOSIS, SURGICAL; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; CISPLATIN; COMBINED MODALITY THERAPY; EPOETIN ALFA; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUOROURACIL; GASTRECTOMY; HEMOGLOBINS; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33745202810     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.01.097     Document Type: Article

References (30)

1. Demetri G.D. Anaemia and its functional consequences in cancer patients. current challenges in management and prospects for improving therapy. Br J Cancer 84 Suppl 1 (2001) 17-23
2. Ludwig H., and Strasser K. Symptomatology of anemia. Semin Oncol 28 Suppl 2 (2001) 7-14
3. Glaspy J. Anemia and fatigue in cancer patients. Cancer 92 Suppl 6 (2001) 1719-1724
4. Caro J.J., Salas M., Ward W., et al. Anemia is an independent prognostic factor for survival in patients with cancer. Cancer 91 (2001) 2214-2221
5. Littlewood T.J., Bajetta E., Nortier J.W.R., et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy. results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19 (2001) 2865-2874
6. Grogan M., Thomas G.M., Melamed I., et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86 (1999) 1528-1536
7. Glaser C.M., Millesi W., Kornek G.V., et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50 (2001) 705-715
8. Blohmer J.U., von Minckwitz G., Paepke S., et al. Sequential adjuvant chemo-radiotherapy with vs. without erythropoietin for patients with high-risk cervical cancer-second analysis of a prospective randomized, open and controlled AGO- and NOGGO-intergroup study. [Abstract]. Proc Am Soc Clin Oncol 21 (2002) 206A (abstract 823)
9. Kosmadakis N., Messaris E., Maris A., et al. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer. prospective randomized double-blind study. Ann Surg 237 (2003) 417-421
10. Busch O., Hop W., Hoynck van Papendrecht M., Marquet R.L., and Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328 (1993) 1372-1376
11. Burrows L., and Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 2 (1982) 662
12. Fong Y., Karpeh M., Mayer K., and Brennan M.F. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 167 (1994) 256-260
13. Jones K.R., and Weissler M.C. Blood transfusion and other risk factors for recurrence of cancer of the head and neck. Arch Otolaryngol Head Neck Surg 116 (1990) 304-309
14. Rosenberg S.A., Seipp C.A., White D.E., and Wesley R. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol 3 (1985) 698-709
15. Yamamoto J., Kosuge T., Takayama T., et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 115 (1994) 303-309
16. Dresner S.M., Lamb P.J., Shenfine J., Hayes N., and Griffin S.M. Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 26 (2000) 492-497
17. Langley S.M., Alexiou C., Bailey D.H., and Weeden D.F. The influence of perioperative blood transfusion on survival after esophageal resection for carcinoma. Ann Thorac Surg 73 (2002) 1704-1709
18. Voelter V., Schuhmacher C., Busch R., Peschel C., Siewert J.R., and Lordick F. Incidence of anemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer. Ann Thorac Surg 78 (2004) 1037-1041
19. Siewert J.R., and Stein H.J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85 (1998) 1457-1459
20. Gehan E.A. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chronic Dis 13 (1961) 346-353
21. Abels R.I., Larholt K.M., Krantz K.D., and Bryant E.C. Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer. Oncologist 1 (1996) 140-150
22. Ludwig H., Fritz E., Kotzmann H., Hocker P., Gisslinger H., and Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322 (1990) 1693-1699
23. Bokemeyer C., Aapro M.S., Courdi A., et al. EORTC guidelines for the use of erythropoietin proteins in anaemic patients with cancer. Eur J Canc 40 (2004) 2201-2216
24. Chung M., Steinmetz O.K., and Gordon P.H. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 80 (1993) 427-431
25. Lutterbach J., and Guttenbacher R. Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic pharynx. Int J Radiat Oncol Biol Phys 48 (2000) 1345-1350
26. Frommhold H., Guttenberger R., and Henke M. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther Onkol 147 Suppl 14 (1998) 31-34
27. Henke M., Laszig R., Schäfer U., et al. Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy. randomized, double-blind, placebo-controlled trial. Lancet 362 (2003) 1255-1260
28. Lordick F., Stein H.J., Peschel C., and Siewert J.R. Neoadjuvant therapy for oesophagogastric cancer. Br J Surg 91 (2004) 540-551
29. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer. a randomized controlled trial. Lancet 359 (2002) 1727-1733
30. Cunningham D., Allum W.H., Stenning S.P., and Weeden S. Perioperative chemotherapy in operable gastric and lower oesophageal cancer. final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). Proc Am Soc Clin Oncol 24 (2005) (abstract 4001)